openPR Logo
Press release

4th International Conference on Hypertension & Healthcare

01-30-2018 12:39 PM CET | Health & Medicine

Press release from: Conference Series Ltd

4th International Conference on Hypertension & Healthcare

We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension & Stroke, Advanced Treatment Approaches and many more.

This format has proven to be extremely popular with Clinicians and researchers, Heads, Deans and Professors of Hypertension or Cardiology departments. I do hope you will mark this date in your calendar, check the website for updates and join us in Zurich for what promises to be another exciting, cutting edge exploration of the latest advances in hypertension and cardiovascular diseases.

Theme of the conference: Control Hypertension: Add life to Longevity

For more details of the conference please have a glance at our website: https://hypertension.conferenceseries.com/

Conference Highlights
Hypertension
High Blood Pressure and Kidney Diseases
Pulmonary Hypertension
Gestational Hypertension
Hypertension & Stroke
Hypertension and Diabetes
Hypertensive Heart Disease
Evaluation of Hypertension
Causative Factors, Risk Assessment and Complications
Diagnosis and Pathophysiology of Hypertension
Anti- Hypertensive Medications
Hypertension Therapy Devices
Diet and lifestyle in Hypertension Management
Nursing Management of Hypertension
Advanced Treatment Approaches
Clinical Trials and Case Reports

For Abstract submission please visit the link :https://hypertension.conferenceseries.com/abstract-submission.php

We look forward to welcoming you to Zurich!

Conference Series LLC through its Open Access Initiative is committed to create real and reliable contributions to the scientific community. Conference Series Ltd organize 600+ Conferences once a year across USA, Europe & Asia with support from a thousand additional scientific societies and Publishes 400+ Open access journals that contains over 30000 eminent personalities, putative scientists as editorial board members.

Jessie Alison
Program Director
Hypertension 2018
Kemp House, 152 City Road, London EC1V 2NX
Email: hypertension@cardiologyconference.org
Phone No: +44-8000148923

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 4th International Conference on Hypertension & Healthcare here

News-ID: 922502 • Views:

More Releases for Hypertension

Hypertension Pipeline Outlook Report 2024 (Updated)
DelveInsight's, "Hypertension Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Hypertension pipeline landscape. It covers the Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hypertension pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Hypertension Pipeline Report • DelveInsight's Hypertension
Hypertension Drugs Market - Breaking the Pressure: Hypertension Drugs Redefining …
Newark, New Castle, USA: The "Hypertension Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Hypertension Drugs Market: https://www.growthplusreports.com/report/hypertension-drugs-market/8760 This latest report researches the industry structure, sales, revenue,
Hypertension Management Devices Market: Rise in Prevalence of Resistant Hyperten …
Market Analysis and Insights of Hypertension Management Devices Market Hypertension Management Devices Market to account USD 9.50 billion and growing at a CAGR of 7.27% by 2032. Although there are still numerous variations available, the major market players are currently developing and testing clinical versions of hypertension treatment devices. Due to the lack of available effective medications, these medical devices are being created with the primary goal of managing cardiovascular illnesses
Anti-hypertension - Drug Pipeline Landscape, 2022
Hypertension also known as high blood pressure is a condition where the force of blood pushing against the arterial walls of heart is consistently higher than the normal. Hypertension can be identified as primary/essential (without a known cause such as age, genetics, sedentary lifestyle, alcohol consumption, high sodium intake etc.) and secondary (due to an underlying condition as its cause such as congenital heart defects, kidney diseases, endocrinal issues, side
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
Renal Hypertension: Diagnosis & Treatment
“Hypertension & Cardiovascular disease after Kidney Transplantation” is one of the workshops to be conducted by Dr. Hossein Tabriziani of Loma Linda University, USA under the session ‘Renal Hypertension’ at the meeting 2nd International Conference on Hypertension & Healthcare which is going to be held at Amsterdam, Netherlands during September 11-13, 2017. High blood pressure is a leading cause of kidney disease and kidney failure ESRD (end stage renal disease). Hypertension